Dr Mercola supporting the use of LDN in RA

[Guest guest]

I thought you would all be interested in this article with

Dr Mercola’s comments:-

The " New " Kid on the Block -- Low-Dose

Naltrexone

One new addition

to my RA protocol is low-dose

Naltrexone, which I would encourage anyone with RA to try. It is inexpensive

and non-toxic, and I have a number of physician reports documenting incredible

efficacy in getting people off of all their dangerous arthritis medications.

The drugs

typically used for rheumatoid arthritis are some of the most dangerous drugs

used in medicine. High doses of prednisone are common, as well as

immunosuppressants and anti-cancer agents to treat the severe pain and

swelling.

Low-dose

Naltrexone, however, does not fall into this dangerous category.

Naltrexone

(generic name) is a pharmacologically active opioid antagonist, conventionally

used to treat drug- and alcohol addiction – normally at doses of 50mg to

300mg. As such, it's been an FDA approved drug for over two decades.

However,

researchers have found that at very low dosages (3 to 4.5 mg),

naltrexone has immunomodulating properties that may be able to successfully

treat a wide range of autoimmune diseases, including rheumatoid

arthritis, multiple sclerosis (MS), Parkinson's,fibromyalgia,

and Crohn's

disease, just to name a few.

For a more

in-depth review of low-dose Naltrexone and how it can help RA sufferers, please

see this previous

article.

In this article it states “chronic inflammation in the

body” – here’s the link http://www.foodconsumer.org/newsite/Non-food/Disease/Rheumatoid Arthritis_on_the_rise_in_women_1706100538.html

Jayne Crocker

Chairperson

www.LDNNow.com

Important! Please sign our LDN petition to the

European Parliament by clicking here

tel: +44 (0) 7877 492 669

Dr Steele MBE, talking about LDN

LDNNow are a political/pressure group of individuals

dedicated to getting Low Dose Naltrexone (LDN) accepted into modern medicine

and trialled for the myriad of uses it shows benefit for.

..